Fragile X syndrome (FXS) is the most common cause of inherited intellectual disability and the most common known genetic cause of autism or autism spectrum disorders. FXS is caused by silencing or mutation of the fragile X mental retardation gene (FMR1), a known RNA-binding protein that acts as a negative regulator of translation [1,2]. FXS patients demonstrate a myriad of symptoms that can vary widely between individuals, including impaired cognition, physical abnormalities, sleep problems, hyperarousal to sensory stimuli, increased anxiety, obsessive compulsive disorder-like behavior, attention-deficit hyperactive disorder symptoms, self-injurious behavior, aggression, and increased risk of seizures [3]. The molecular mechanisms underlying FXS are not clear, and currently there is no ideal treatment.The Drosophila homolog of mammalian FMR1, dFMR1, contains several highly conserved domains that are also found in human FMR1 [1]. Loss of dFMR1 or expressing a mutant that carries deletions or point mutations in the coding region can lead to several behavioral and anatomical defects in the fly, including defects in learning and memory, social interaction, circadian rhythm, and sleep [2,[4][5][6][7], many of which are similar to those seen in FXS patients. The conservation of FMR1 protein between Drosophila and human, as well as the similarity in phenotypes when the gene is disrupted makes it possible to use fruit fly, this powerful, fast, and cost-effective genetic model, to investigate the molecular mechanism underlying FXS and facilitate drug development.In a recent paper published in Molecular Psychiatry [8], researchers from the University of Pennsylvania uncovered misregulated insulin signaling (IS), which contributes to circadian and memory deficits in the Drosophila FXS model. Expression of dfmr1 in the insulin-producing cells of the brain is sufficient to rescue the memory deficits and restore normal circadian behavior in dfmr1 mutant flies. Moreover, the protein level of insulin-like peptide DILP2 is elevated in dfmr1 mutant flies. What is the consequence of increased DILP2 in the brain? A GFP-pleckstrin homology (PH) domain reporter was used by the authors to monitor the activation of phosphoinositide 3-kinase (PI3K), and increased membrane localization of the reporter was detected in dfmr1 mutant brains, indicating stronger PI3K activation. As PI3K is known to phosphorylate Akt at S505, the authors next examined phosphorylation at this particular site. Consistently, an enhanced p-S505-Akt signal was detected at the plasma membrane of dfmr1 mutants, further validating elevated PI3K signaling in these flies. Moreover, rescuing dfmr1 significantly decreased DILP2, membrane GFP-PH, and p-S505-Akt levels, indicating that the increased IS observed is indeed due to a lack of dFMR1. Does elevated IS lead to the circadian and cognitive phenotypes? To address this, the authors expressed a dominant-negative form of the 110-kDa catalytic subunit of PI3K (DP110 DN ) which reduces its activity, or the phosphatase and ...